Efficacy of NY-198 against experimental Legionnaires disease.
The in vitro and in vivo effects of NY-198 against Legionella pneumophila were compared with those of ciprofloxacin. The MIC of NY-198 against 15 standard reference strains of Legionella of various species, between 0.03 and 0.125 micrograms/ml, was the same as that of ciprofloxacin. The peak concent...
Bewaard in:
| Gepubliceerd in: | Antimicrob Agents Chemother |
|---|---|
| Hoofdauteurs: | , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
American Society for Microbiology (ASM)
1988
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC175881/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3196003/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.32.9.1427 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|